Assessing cardiovascular risk in rheumatoid arthritis patients on Janus kinase inhibitors: real-world data from the European Alliance of Associations for Rheumatology-adapted CUORE risk algorithm

Janus kinase inhibitors (JAKi) are effective treatments for rheumatoid arthritis (RA), but growing evidence raises cardiovascular (CV) safety concerns. Given the elevated baseline CV risk in RA, appropriate risk stratification is essential. We retrospectively analyzed 116 RA patients treated with JA...

Full description

Bibliographic Details

Published in:	Rheumatology
Main Authors:	Marco Tasso, Luisa Costa, Nicoletta Bertolini, Antonio Del Puente, Rosario Peluso, Alfonso Oriente, Francesca Foglia, Mario Cascone, Francesco Caso
Format:	Article
Language:	English
Published:	Termedia Publishing House 2025-08-01
Subjects:	janus kinase inhibitors rheumatoid arthritis cardiovascular risk cuore algorithm
Online Access:	https://reu.termedia.pl/Assessing-cardiovascular-risk-in-rheumatoid-arthritis-patients-on-Janus-kinase-inhibitors,207507,0,2.html